Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice
Ronald Witteles(Alnylam Pharmaceuticals (United States)), Pablo García‐Pavía(Universidad Francisco de Vitoria), Claudio Rapezzi(University of Ferrara), Sabahat Bokhari(Boston University), Thibaud Damy(Amyloidosis Foundation), Rodney H. Falk(Brigham and Women's Hospital), Laura Obici(University of Pavia), Perry Elliott(St Bartholomew's Hospital), Мариана Господинова(Ministry of Interior), Nowell M. Fine(University of Calgary)
Cited by 345
Related Papers
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
|European Heart Journal|2013|3.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k